bf/NASDAQ:ACLX_icon.png

COM:ARCELLX

Arcellx, Inc.

  • Stock

USD

Last Close

87.22

22/11 21:00

Market Cap

3.07B

Beta: -

Volume Today

342.91K

Avg: -

  • name

    Arcellx, Inc.
  • homepage url

    arcellx.com
  • country

    USUnited States
  • linkedin url

    arcellx
  • crunchbase url

    arcellx
  • employee count

    130
  • sector

    Healthcare
  • industry

    Biotechnology
  • revenue

    110.32M

Description

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an ...Show More

peer of

competitor of